BioSilta Overview

  • Founded
  • 2007
  • Status
  • Out of Business
  • Employees
  • 11
  • Latest Deal Type
  • Out of Business

BioSilta General Information


Operator of a biotechnology company designed to develop and market reagent based microbial growth systems and accessories for the healthcare sector. The company's EnBase technology platform develop innovative, reagent-based EnPresso growth systems, enabling customers to increase the yield of high quality biomolecules from microbial cultures.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 8 Bramley Road
  • Saint Ives
  • Cambridgeshire PE27 3WS
  • England, United Kingdom
+44 01480 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioSilta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 03-Jun-2017 00.000 Completed Out of Business
3. Later Stage VC 11-Jun-2014 00.000 00.000 Completed Generating Revenue
2. Early Stage VC 16-Nov-2011 $1.38M $1.38M Completed Startup
1. Early Stage VC 22-Feb-2008 Completed Startup
To view BioSilta’s complete valuation and funding history, request access »

BioSilta Executive Team (5)

Name Title Board Seat Contact Info
Robert Penney Chief Executive Officer
Paul Whitaker Board Member & Managing Director
Stuart Bradley Commercial Director
Antti Vasala Ph.D Director, Research & Development
Peter Neubauer Ph.D Chief Scientific Officer, Board Member & Co-Founder
To view BioSilta’s complete executive team members history, request access »

BioSilta Board Members (7)

Name Representing Role Since
Mark Bloomfield Self Chairman 000 0000
Paul Whitaker BioSilta Board Member & Managing Director 000 0000
Peter Neubauer Ph.D Self Chief Scientific Officer, Board Member & Co-Founder 000 0000
You’re viewing 3 of 7 board members. Get the full list »

BioSilta Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial